Friday, June 27, 2025
HomeTagsBiopharmaceutical company

biopharmaceutical company

Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D for Autoimmune Focus

Nkarta, a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, announced the appointment of Shawn Rose, M.D. Ph.D.,...

Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development

Contineum Therapeutics, a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, announced the appointment of Timothy...

Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors

Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, ...

Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T

Precigen, Inc, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced the amendment...

Xeris Biopharma Appoints Ricki Fairley to Board of Directors

Xeris Biopharma Holdings , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics